AP9801350A0 - Parasitical formulations. - Google Patents

Parasitical formulations.

Info

Publication number
AP9801350A0
AP9801350A0 APAP/P/1998/001350A AP9801350A AP9801350A0 AP 9801350 A0 AP9801350 A0 AP 9801350A0 AP 9801350 A AP9801350 A AP 9801350A AP 9801350 A0 AP9801350 A0 AP 9801350A0
Authority
AP
ARIPO
Prior art keywords
parasitical
formulations
administer
convenient
protection against
Prior art date
Application number
APAP/P/1998/001350A
Inventor
Hiep Huatan
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of AP9801350A0 publication Critical patent/AP9801350A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Abstract

The invention provides a solid implant comprising at least one parasiticidal compound having low aqueous solubility; and tabletting excipients including a bulking agent. Implants according to the invention are convenient to administer and provide prolonged protection against parasites.
APAP/P/1998/001350A 1997-09-23 1998-09-17 Parasitical formulations. AP9801350A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations

Publications (1)

Publication Number Publication Date
AP9801350A0 true AP9801350A0 (en) 2000-03-17

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001350A AP9801350A0 (en) 1997-09-23 1998-09-17 Parasitical formulations.

Country Status (13)

Country Link
EP (1) EP1014970A1 (en)
JP (1) JP2001517622A (en)
AP (1) AP9801350A0 (en)
AR (1) AR013509A1 (en)
AU (1) AU9742298A (en)
BR (1) BR9812385A (en)
CA (1) CA2304283A1 (en)
GT (1) GT199800149A (en)
MA (1) MA24655A1 (en)
PA (1) PA8459501A1 (en)
PE (1) PE117199A1 (en)
TN (1) TNSN98175A1 (en)
WO (1) WO1999015166A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
AU1556000A (en) * 1999-11-22 2001-06-04 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (en) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintics to prevent parasitic infections in humans and animals
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
US20200179273A1 (en) * 2017-06-06 2020-06-11 Merck Sharp & DohmeCorp Long-action implant for treatment of infectious diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (en) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectins as growth promotant agents
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
PA8459501A1 (en) 2000-05-24
BR9812385A (en) 2000-09-12
WO1999015166A1 (en) 1999-04-01
CA2304283A1 (en) 1999-04-01
AR013509A1 (en) 2000-12-27
MA24655A1 (en) 1999-04-01
PE117199A1 (en) 1999-11-20
TNSN98175A1 (en) 2005-03-15
GT199800149A (en) 2000-03-15
EP1014970A1 (en) 2000-07-05
JP2001517622A (en) 2001-10-09
AU9742298A (en) 1999-04-12

Similar Documents

Publication Publication Date Title
WO2000041681A3 (en) MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST
MY118151A (en) Pharmaceutical formulations containing voriconazole.
AU2000279625A1 (en) Blood mmp-3 level-lowering agent containing il-6 antgonist as the active ingredient
HK1034183A1 (en) Galenic formulations of meloxicam for oral administration.
BG66093B1 (en) Controlled release compositions comprising nimesulide
AU1276501A (en) Active ingredient combination having insecticidal and acaricidal characteristics
BG106586A (en) Pyrazolopyramidines as therapeutic agents
IL153297A0 (en) Compounds and compositions for delivering active agents
HK1024182A1 (en) Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations
ZA200003121B (en) Flash-melt oral dose formulations.
CA2339765A1 (en) Compounds and compositions for delivering active agents
MXPA01008611A (en) Compounds and compositions for delivering active agents.
GB0025173D0 (en) Therapeutic agents
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
SE0102843D0 (en) Stabilized oral pharmaceutical composition containing lodide and lodate and method
IL146025A0 (en) Improved pharmaceutical formulations comprising at least one hiv protease inhibiting compound
AU2001284413A1 (en) Medicinal compositions for preventing or treating heart failure
SI1121127T1 (en) Oral pharmaceutical compositions containing buprenorphin
AP9801350A0 (en) Parasitical formulations.
WO2002015959A3 (en) Compounds and compositions for delivering active agents
NO994431L (en) New wording
GB9907571D0 (en) Compounds
ZA200201807B (en) Active ingredient combinations having insecticidal and acaricidal properties.
EP1328236A4 (en) Methods of decreasing or preventing pain using spicamycin derivatives